ACAD CIK: 1070494

Acadia Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.62
FY22:
0.51
FY23:
0.62
FY24:
0.94
FY25:
1.06
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.08
FY23:
0.13
FY24:
0.25
FY25:
0.50
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.70
FY22:
0.59
FY23:
0.75
FY24:
1.19
FY25:
1.56

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.13
FY23:
0.25
FY24:
0.39
FY25:
0.28
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.06
FY22:
0.06
FY23:
0.06
FY24:
0.06
FY25:
0.06
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.54
FY22:
0.40
FY23:
0.43
FY24:
0.73
FY25:
1.23
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.70
FY22:
0.59
FY23:
0.75
FY24:
1.19
FY25:
1.56

All amounts in billions USD Data sources:SEC EDGARTwelve Data